Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BLB-201 by Blue Lake Biotechnology for Respiratory Syncytial Virus (RSV) Infections: Likelihood of Approval
BLB-201 is under clinical development by Blue Lake Biotechnology and currently in Phase II for Respiratory Syncytial Virus (RSV) Infections....